Clinical Trial Update: Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial in Malaysia evaluating the combination of gemcitabine and carboplatin for metastatic or recurrent Nasopharyngeal Carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Ministry of Health, Malaysia | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED